Roth MKM Reaffirms Their Buy Rating on NEXTracker, Inc. Class A (NXT)
Roth MKM analyst Philip Shen reiterated a Buy rating on NEXTracker, Inc. Class A (NXT – Research Report) yesterday and set a price target of $70.00. The company's shares closed yesterday at $55.04.
Confident Investing Starts Here:
Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Shen covers the Technology sector, focusing on stocks such as First Solar, Array Technologies, and Daqo New Energy. According to TipRanks, Shen has an average return of 5.2% and a 39.87% success rate on recommended stocks.
In addition to Roth MKM, NEXTracker, Inc. Class A also received a Buy from RBC Capital's Chris Dendrinos in a report issued yesterday. However, on the same day, Guggenheim downgraded NEXTracker, Inc. Class A (NASDAQ: NXT) to a Hold.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
HubSpot, Inc. (HUBS): A Bull Case Theory
We came across a bullish thesis on HubSpot, Inc. (HUBS) on Compouding Your Wealth's Substack. In this article, we will summarize the bulls' thesis on HUBS. HubSpot, Inc. (HUBS)'s share was trading at $578.25 as of 29th May. HUBS's forward P/E was 61.73 according to Yahoo Finance. A person using a laptop with a blue background showing the software platform's user inteface. HubSpot reported strong financial results for Q1 2025, with revenue reaching $714.1 million, a 15.7% increase year-over-year and 20.8% quarter-over-quarter growth, surpassing estimates by 2.3%. Subscription revenue, which makes up nearly 98% of total revenue, grew by the same rate, highlighting continued customer demand for its core offerings. While gross margin declined slightly by 0.7 percentage points to 83.9%, and operating margin dropped by 0.9 points to 14%, free cash flow margin improved modestly to 17.1%. Net margin was negative 3.1%, reflecting a 4-point decrease from the prior year, largely influenced by non-GAAP adjustments and timing of certain expenses. Earnings per share of $1.78 exceeded expectations by 1.7%. Key metrics such as deferred revenue and remaining performance obligations showed significant growth, up nearly 20% and 37% respectively, underscoring strong future revenue visibility. Billings rose by 19.6%, though average revenue per customer declined slightly by 3.6%, signaling some pressure on pricing or customer mix. Customer count increased by 19.1% to over 258,000. On the operational side, sales and marketing efficiency improved with S&M expense as a percentage of revenue falling by 1.6 points, while R&D and G&A expenses rose modestly as a share of revenue. The company highlighted its rapid product innovation with over 200 new features released, particularly embedding AI across its platform and expanding enterprise capabilities. AI-powered tools like Customer Agent have driven measurable improvements in sales and support efficiency. HubSpot raised its full-year revenue guidance to approximately $3.04 billion, projecting continued growth fueled by a combination of seat expansion and consumption-based AI monetization, while maintaining a cautious view on macroeconomic uncertainty. For a comprehensive analysis of another standout stock covered by the same author, we recommend reading our summary of this bullish thesis on Shopify Inc. (SHOP). HubSpot, Inc. (HUBS) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 61 hedge fund portfolios held HUBS at the end of the first quarter which was 73 in the previous quarter. While we acknowledge the potential of HUBS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey.
Yahoo
an hour ago
- Yahoo
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, June 06, 2025--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer's Board of Directors approved the grant, effective June 5th, 2025, to three non-executive employees of non-qualified stock option awards to purchase up to an aggregate of 69,875 shares of the Company's common stock under the Gossamer Bio, Inc. 2023 Employment Inducement Incentive Award Plan ("2023 Inducement Plan"). The awards were granted as an inducement material to the employees entering into employment with Gossamer in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.26 per share, which is equal to the closing price of Gossamer's common stock as reported by The Nasdaq Global Select Market on June 5th, 2025. The options have a ten-year term and will vest over four years, with 25% vesting on the one-year anniversary of the applicable vesting commencement date and the balance of the shares vesting in a series of 36 successive monthly installments thereafter, subject to the employees' continued employment with Gossamer on such vesting dates. The options are subject to the terms and conditions of the 2023 Inducement Plan and the terms and conditions of a stock option agreement covering the grants. About Gossamer Bio Gossamer Bio is a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. Its goal is to be an industry leader in, and to enhance the lives of patients living with, pulmonary hypertension. View source version on Contacts For Investors and Media: Bryan Giraudo, Chief Operating Officer and Chief Financial OfficerGossamer Bio Investor Relationsir@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
an hour ago
- Yahoo
How to win prizes by exploring Downtown Dayton
DAYTON, Ohio (WDTN) — To prepare for the official kickoff of summer, a local organization is holding a fun event for people to win prizes. From June 6 to Sept. 12, individuals can visit different spots in downtown Dayton for the 2025 Downtown Dayton Summer Passport. By visiting certain spots, participants will earn stamps for their passport. More than 70 businesses in the city are participating in the summer fun. Eight locations across the Gem City are available for those interested to pick up their summer passport. Once you have received 16 stamps from participating businesses, you can return the passport to any of the eight pick-up locations. Passports must be returned before Sept. 12. Prizes available in the contest range from items like a Dayton prize pack, gift cards, hotel stay and more. To participate, you must be at least 18 years old. Additional details are avaliable here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
